About 3,370 results
Open links in new tab
  1. Canadian Migraine Sufferers Have New Treatment …

    WEBNov 16, 2022 · UBRELVY® is the first oral CGRP receptor antagonist (gepant) approved by Health Canada for the acute treatment of migraine. It reduces or eliminates migraine pain with a single tablet, with the ...

  2. Latest Health, Healthcare News and Press Releases - Newswire

  3. Press Release Distribution Service | Newswire

  4. Health Canada Approves AbbVie's RINVOQ® (upadacitinib) for …

  5. Wegovy® (semaglutide injection) available in Canada - Newswire

  6. Health Canada Authorizes POLIVY® (polatuzumab vedotin for

  7. Cision | News Releases - Newswire

  8. All News Releases | Cision Canada - Newswire

  9. QULIPTA™ Now Approved by Health Canada for the Preventive

  10. RBC completes acquisition of HSBC Bank Canada - Newswire